Diffuse Large B-Cell Lymphoma — Trials

Diffuse Large B-Cell Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

1,150 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 355
Recruiting: 190
Ph III recruiting: 16
Growth YoY: −8.8%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 38.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (177)

clinicaltrialsPublishedShowing 1–6 of 6 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03226704	Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing	enrolling by invitation	—	120	National Cancer Institute (NCI)NIH	1	Sep 22, 2026	clinicaltrials
NCT03628612	Long-term Follow-up of Patients Treated With Genetically Modified Autologous T Cells	enrolling by invitation	Phase 2	500	Autolus LimitedINDUSTRY	3	Sep 22, 2026	clinicaltrials